Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum. - Test2 - elhamkhani - TriplyDB

Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum.

Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum.

http://www.wikidata.org/entity/Q36280125

about

A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum Applications of targeted proteomics in systems biology and translational medicine Advances in targeted proteomics and applications to biomedical research Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.Highly multiplexed and reproducible ion-current-based strategy for large-scale quantitative proteomics and the application to protein expression dynamics induced by methylprednisolone in 60 rats.Quantitative proteomics in cardiovascular research: global and targeted strategies Towards identification of true cancer biomarkers.Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer.Expediting SRM assay development for large-scale targeted proteomics experiments.Toward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry.Protein analysis by shotgun/bottom-up proteomics Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.Sensitive targeted quantification of ERK phosphorylation dynamics and stoichiometry in human cells without affinity enrichment.Liquid phase based separation systems for depletion, prefractionation, and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis-An update covering the period 2011-2014.Quantitative Profiling of Protein Tyrosine Kinases in Human Cancer Cell Lines by Multiplexed Parallel Reaction Monitoring Assays Advances in Proteomic Technologies and Its Contribution to the Field of Cancer Compensatory Islet Response to Insulin Resistance Revealed by Quantitative Proteomics.Quantitative mass spectrometry analysis of PD-L1 protein expression, N-glycosylation and expression stoichiometry with PD-1 and PD-L2 in human melanoma.Protein target quantification decision tree.Deciphering the biological effects of acupuncture treatment modulating multiple metabolism pathways.The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.The NINDS Parkinson's disease biomarkers program.Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids Targeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletion Ratiometric Measurements of Adiponectin by Mass Spectrometry in Bottlenose Dolphins (Tursiops truncatus) with Iron Overload Reveal an Association with Insulin Resistance and Glucagon Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathway Long-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis.Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma.Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag.Simplified and efficient quantification of low-abundance proteins at very high multiplex via targeted mass spectrometry.Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies.Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology.Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer.

P2860

Q24307894-9CE16675-24EE-442C-A024-3E48EBFE9E60 Q26852271-AAE8EFA0-A433-4F9A-AA25-9523C71BBBBF Q28066912-C0870903-3563-4362-B8AA-783F55B39B70 Q28307595-4D683D43-1E7B-42B3-A74C-33520484F49B Q33745617-8AA9C18E-1315-4847-86CC-1AC15D89CDB8 Q33850616-BAFF55E7-72AB-4F82-9854-11D9992301AB Q34070221-B207CFC6-3C19-4FB7-9E60-8465D1BFE814 Q34156082-99FF1073-6AA3-4F5A-8D00-EF515AF12A04 Q34168702-0D49DC99-4C81-4941-9696-1801B2F208B8 Q34283031-5BE01248-9BBB-4942-9B6C-4B651377B2DB Q34286018-C533D975-D3D1-4271-931C-2307923AFE12 Q34359998-701A6596-3B61-4B5B-A4DA-5EE75F064803 Q34600986-849FD922-B5FD-4C0E-95FA-C82C39DD92AD Q34810177-82F39BC7-DA0E-45BE-A550-282ADFC39CE5 Q35125405-F6B6EDC5-F3D4-4EB0-8492-374B275D18AF Q35193821-F205980E-EE14-45E5-B25A-75800E3FD882 Q35799972-67A9790B-BCA2-4A03-824B-B223C772482E Q35859573-7CFE0E01-A48F-4D9B-8C16-61B56AFF9FDC Q36112651-AB3B6E5C-1DA4-40F0-B1C9-7FDC16108EDB Q36191447-2688A662-C3E6-4AEF-97FB-008223DE02EB Q36382143-FA3DDEDD-17DD-4187-AD49-D6E89F09FD48 Q36582456-FD0ED899-B55E-4093-A3E5-F1AD5CBC3B39 Q36583023-A5C803E7-4A18-4FC3-872F-5E1AE195EC94 Q36771005-4F5C9D65-425D-4C16-B90F-497563B50468 Q36777618-8EAA8168-08DE-4650-B540-4803B55F5016 Q36889137-B89454A8-F437-422C-82B0-009E4327CCD0 Q37069906-15434C21-921F-4AE6-83EB-2EA80E584245 Q37186111-84DA9B11-F9EE-4247-93B2-6F3897AD9FBF Q37238264-2618382D-9262-45DF-AF30-77D7A54BFF9E Q37284069-F97E64AE-7DA2-4658-8F36-7D8AB7290CEA Q37341145-055E38F5-F28D-4309-9435-D2B592412F93 Q37394942-824CBF36-C7FE-4CA8-BF0F-5397073B546E Q37618631-0F989D4C-8401-4BB5-9900-CC1CD569DD35 Q37623655-F484C078-12B2-4665-B262-350295C6C0F7 Q37635618-C2F8FBC7-9B2B-4A9A-BE2B-061C90D20EB5 Q37687439-EC7803BC-8C80-4006-9001-862CB9AC5060 Q38160931-446553E9-F635-4523-B843-39ADCA51BC69 Q38164428-94A175F8-C3BF-4E52-AA7C-F7548E570EB1 Q38187682-59013CBC-4BE7-49C4-8472-A1981430D19C Q38188878-DC023B16-862E-40D5-A703-65D18F9E851E

P2860

Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum.

http://www.wikidata.org/entity/Q36280125

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Antibody-free, targeted mass-s ...... levels in human plasma/serum.

@ast

Antibody-free, targeted mass-s ...... levels in human plasma/serum.

@en

type

label

Antibody-free, targeted mass-s ...... levels in human plasma/serum.

@ast

Antibody-free, targeted mass-s ...... levels in human plasma/serum.

@en

prefLabel

Antibody-free, targeted mass-s ...... levels in human plasma/serum.

@ast

Antibody-free, targeted mass-s ...... levels in human plasma/serum.

@en

P1433

Q36280125-296FCBE2-3AC2-436C-8E0C-1B0E849D5906

P1476

Q36280125-73828793-5C67-4FD4-8AF7-8138F447F669

P2093

Q36280125-39A89B57-1E55-419B-897F-48E89C716FA9

Q36280125-4567ECFC-42C9-4560-A27C-29DDC0D05ECE

Q36280125-45C01BE7-B75C-4558-B23C-B3EC7BCF9E8C

Q36280125-4D200D42-2FEC-4CDF-8D55-B48FFE0C2B1D

Q36280125-52571D80-2016-4439-AF98-E189CA838899

Q36280125-52B995FF-8C8A-4444-9472-DE6561A72699

Q36280125-7DAFEAD1-7B19-464F-B7CA-CD02BF55615C

Q36280125-96724F64-0575-4021-849C-FEF0F1A2A365

Q36280125-9B8554DA-6D12-4282-99FC-5774142B0B10

Q36280125-A653DC85-3176-4F81-942F-8D8298B5A478

P2860

Q36280125-04ADA8F3-B749-415D-B046-16B057FB5E3F

Q36280125-05DE9220-56A7-4178-BC0D-5959B3FCE730

Q36280125-132B0020-6381-4065-BDF5-6F931669C7E5

Q36280125-24AF802E-2EC3-4D9B-B4D8-BFA930BBBEE5

Q36280125-30A90848-2C25-4C90-BFD8-C24181D29688

Q36280125-32212060-45E0-4D33-A99B-6B391ADA8F6F

Q36280125-3CA30C36-145A-4FB7-95D0-254D377640E3

Q36280125-43EE187F-A3DD-4BB5-AE9F-D943A770795E

Q36280125-4D1C99DC-F932-42B0-B111-0A30E2007BB3

Q36280125-512AC482-F9DB-4D34-A950-11708C549DE9

P304

Q36280125-BFEA0406-F707-4965-B206-1ACD194D85D7

P31

Q36280125-851A9876-8FFD-4D6C-9F5A-944C7FCE678E

P356

Q36280125-DBAFF2AB-8010-41BD-B231-09A99E914BB9

P407

Q36280125-C896CC67-FE5B-45C5-87D5-29B131EE3D3C

P433

Q36280125-03DC2844-1AC9-49B5-828F-C9E70C8A117B

P478

Q36280125-2B505F55-BBBE-4B14-B882-355605E95A63

P50

Q36280125-32ED23ED-5B53-421F-B49A-29583B652567

Q36280125-38E08FC2-EFBA-4594-AA03-DB5D12FA1D1E

Q36280125-A3227FF1-DB2E-4084-B8BD-C1D0D43F7468

P577

Q36280125-07654E49-2B98-47BD-B5FC-956AFA266A20

P5875

Q36280125-DEB6BCC3-64E1-4877-9F2A-9107F345B706

P698

Q36280125-ED709540-32D0-44A9-B0B7-73BA2B296979

P921

Q36280125-D6A9EB01-5BD2-4A4F-847F-927CD028EE6E

P932

Q36280125-2DE804FF-94DF-4CA0-AB39-241C830E4927

P356

PNAS.1204366109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Antibody-free, targeted mass-s ...... levels in human plasma/serum.

@en

P2093

David G Camp

http://www.w3.org/2001/XMLSchema#string

Fang Xie

http://www.w3.org/2001/XMLSchema#string

Jacob Kagan

http://www.w3.org/2001/XMLSchema#string

Jong-Seo Kim

http://www.w3.org/2001/XMLSchema#string

Karin D Rodland

http://www.w3.org/2001/XMLSchema#string

Keqi Tang

http://www.w3.org/2001/XMLSchema#string

Ljiljana Pasa-Tolić

http://www.w3.org/2001/XMLSchema#string

Mahmud Hossain

http://www.w3.org/2001/XMLSchema#string

Nathan Jones

http://www.w3.org/2001/XMLSchema#string

Ronald J Moore

http://www.w3.org/2001/XMLSchema#string

P2860

Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor

Mutant proteins as cancer-specific biomarkers

Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry

Expediting the development of targeted SRM assays: using data from shotgun proteomics to automate method development.

Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans

P304

15395-15400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1204366109

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Richard D. Smith

Athena A Schepmoes

P577

2012-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230798538

http://www.w3.org/2001/XMLSchema#string

P698

22949669

http://www.w3.org/2001/XMLSchema#string

P921

P932

3458402

http://www.w3.org/2001/XMLSchema#string